Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2007

01.06.2007 | Radiation

Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease—Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004

verfasst von: James Jabbour, BSc(Med), MBBS, MPH, Robert Cumming, MBBS, MPH, PhD, Richard A. Scolyer, MD, FRCPA, George Hruby, MBBS, FRANZCR, John F. Thompson, MD, FRACS, Stephen Lee, MBBS, FACD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Wide surgical excision, lymph node dissection, and radiotherapy have been used with varying efficacy in the management of early-stage Merkel cell carcinoma.

Methods

Records of 82 patients with early-stage Merkel cell carcinoma between 1992 and 2004 were reviewed.

Results

Forty-two patients developed a recurrence, and 44 died during the study period. Twenty-nine patients presented with regional lymph node disease, which was independently associated with diminished survival (hazard ratio [HR], 4.08; 95% confidence interval [CI], 1.55–10.75; P = .005). Lymphadenectomy was independently associated with prolonged disease-free survival (median, 28.5 vs. 11.8 months; HR, .46; 95% CI, .22–.94; P = .034) but not overall survival (P = .25). Margin-negative excision of the primary tumor (60 of 73) was not significantly associated with either prolonged disease-free survival (median, 16 vs. 14 months) or overall survival (median, 54 vs. 34 months). Forty-eight patients received radiotherapy: 36 to the primary site and 31 to the regional lymph nodes. Radiotherapy to both sites was associated with a longer median time to first recurrence (primary site, 24.2 vs. 11.8 months; regional lymph nodes, 46.2 vs. 11.3 months) and survival (primary site, 53.9 vs. 45.7 months; regional lymph nodes, 103.1 vs. 34.2 months). Administration of any radiotherapy was significantly associated with a prolonged time to first recurrence (HR, .39; 95% CI, .20–.75; P = .004) and survival (HR, .39; 95% CI, .18–.82; P = .013) on the Cox regression multivariate analyses.

Conclusions

Adjuvant radiotherapy to the primary site after surgical excision is recommended in early-stage disease. Involved regional lymph nodes should be treated with radiotherapy with or without lymphadenectomy.
Literatur
1.
Zurück zum Zitat Medina-Franco H, Marshall MU, Fiveash J, et al. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 2000; 8:204–8CrossRef Medina-Franco H, Marshall MU, Fiveash J, et al. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 2000; 8:204–8CrossRef
2.
Zurück zum Zitat Poulson M. Merkel-cell carcinoma of the skin. Lancet Oncol 2004; 5:593–9CrossRef Poulson M. Merkel-cell carcinoma of the skin. Lancet Oncol 2004; 5:593–9CrossRef
3.
4.
Zurück zum Zitat Tang C, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer 1978; 42:2311–21PubMedCrossRef Tang C, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer 1978; 42:2311–21PubMedCrossRef
5.
Zurück zum Zitat Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys 1995;31:315–23PubMedCrossRef Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys 1995;31:315–23PubMedCrossRef
7.
Zurück zum Zitat Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1995; 31:325–31PubMedCrossRef Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1995; 31:325–31PubMedCrossRef
8.
Zurück zum Zitat Kokoska ER, Kokoska MS, Brian IC, et al. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg 1997; 174:688–93PubMedCrossRef Kokoska ER, Kokoska MS, Brian IC, et al. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg 1997; 174:688–93PubMedCrossRef
9.
Zurück zum Zitat Shaw JHF, Rumball E. Merkel cell tumour: clinical behaviour and treatment. Br J Surg 1991; 78:138–42PubMedCrossRef Shaw JHF, Rumball E. Merkel cell tumour: clinical behaviour and treatment. Br J Surg 1991; 78:138–42PubMedCrossRef
10.
Zurück zum Zitat Meland NB, Jackson IT. Merkel cell tumour: diagnosis, prognosis, and management. Plast Reconstr Surg 1986; 77:632–8PubMedCrossRef Meland NB, Jackson IT. Merkel cell tumour: diagnosis, prognosis, and management. Plast Reconstr Surg 1986; 77:632–8PubMedCrossRef
11.
Zurück zum Zitat Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: aetiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8:153–8PubMed Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: aetiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8:153–8PubMed
12.
Zurück zum Zitat Yiengpruksawan A, Coit DG, Howard TT, et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991; 126:1514–9PubMed Yiengpruksawan A, Coit DG, Howard TT, et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991; 126:1514–9PubMed
13.
Zurück zum Zitat Allen PJ, Bowne WB, Jacques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005; 23:2300–9PubMedCrossRef Allen PJ, Bowne WB, Jacques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005; 23:2300–9PubMedCrossRef
14.
Zurück zum Zitat Eng TY, Naguib M, Fuller CD, et al. Treatment of recurrent Merkel cell carcinoma: an analysis of 46 cases. Am J Clin Oncol 2004; 27:576–83PubMedCrossRef Eng TY, Naguib M, Fuller CD, et al. Treatment of recurrent Merkel cell carcinoma: an analysis of 46 cases. Am J Clin Oncol 2004; 27:576–83PubMedCrossRef
15.
Zurück zum Zitat Hitchcock CL, Bland KI, Laney RG, et al. Neuroendocrine (Merkel cell) carcinoma of the skin: its natural history, diagnosis, and treatment. Ann Surg 1988; 207:201–7PubMedCrossRef Hitchcock CL, Bland KI, Laney RG, et al. Neuroendocrine (Merkel cell) carcinoma of the skin: its natural history, diagnosis, and treatment. Ann Surg 1988; 207:201–7PubMedCrossRef
16.
Zurück zum Zitat Meyer-Pannwitt U, Kummerfeldt K, Boubaris P, et al. Merkel cell tumour or neuroendocrine skin carcinoma. Langenbecks Arch Chir 1997; 382:349–358 Meyer-Pannwitt U, Kummerfeldt K, Boubaris P, et al. Merkel cell tumour or neuroendocrine skin carcinoma. Langenbecks Arch Chir 1997; 382:349–358
17.
Zurück zum Zitat Eng TY, Boersma MGK, Fuller CD, et al. Treatment of Merkel cell carcinoma. Am J Clin Oncol 2004; 27:510–5PubMedCrossRef Eng TY, Boersma MGK, Fuller CD, et al. Treatment of Merkel cell carcinoma. Am J Clin Oncol 2004; 27:510–5PubMedCrossRef
18.
Zurück zum Zitat Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma: prognosis and management. Ann Surg 1999; 229:97–105PubMedCrossRef Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma: prognosis and management. Ann Surg 1999; 229:97–105PubMedCrossRef
19.
Zurück zum Zitat McAfee WJ, Morris CG, Mendenhall CM, et al. Merkel cell carcinoma: treatment and outcomes. Cancer 2005; 15:1761–4CrossRef McAfee WJ, Morris CG, Mendenhall CM, et al. Merkel cell carcinoma: treatment and outcomes. Cancer 2005; 15:1761–4CrossRef
20.
Zurück zum Zitat Muller A, Keus R, Neumann N, Lammering G, et al. Management of Merkel cell carcinoma: case series of 36 patients. Oncol Rep 2003; 10:577–85PubMed Muller A, Keus R, Neumann N, Lammering G, et al. Management of Merkel cell carcinoma: case series of 36 patients. Oncol Rep 2003; 10:577–85PubMed
21.
Zurück zum Zitat Connelly TJ, Cribier B, Brown TJ, et al. Complete spontaneous regression of the Merkel cell carcinoma: a review of the ten reported cases. Dermatol Surg 2000; 26:853–6PubMedCrossRef Connelly TJ, Cribier B, Brown TJ, et al. Complete spontaneous regression of the Merkel cell carcinoma: a review of the ten reported cases. Dermatol Surg 2000; 26:853–6PubMedCrossRef
22.
Zurück zum Zitat Goepfert H, Remmler D, Silva E, et al. Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck. Arch Otolaryngol 1984; 110:707–12PubMed Goepfert H, Remmler D, Silva E, et al. Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck. Arch Otolaryngol 1984; 110:707–12PubMed
23.
Zurück zum Zitat O’Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma: comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997; 23:929–33PubMedCrossRef O’Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma: comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997; 23:929–33PubMedCrossRef
24.
Zurück zum Zitat Poulsen M, Harvey J. Is there a diminishing role for surgery for Merkel cell carcinoma of the skin? A review of current management. Aust N Z J Surg 2002; 72:142–6CrossRef Poulsen M, Harvey J. Is there a diminishing role for surgery for Merkel cell carcinoma of the skin? A review of current management. Aust N Z J Surg 2002; 72:142–6CrossRef
25.
Zurück zum Zitat Fenig E, Brenner B, Katz A, et al. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997;80:881–5PubMedCrossRef Fenig E, Brenner B, Katz A, et al. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997;80:881–5PubMedCrossRef
26.
Zurück zum Zitat Allen PJ, Zhang ZF, Coit DG. The surgical management of Merkel cell carcinoma. Ann Surg 1999; 229:97–105PubMedCrossRef Allen PJ, Zhang ZF, Coit DG. The surgical management of Merkel cell carcinoma. Ann Surg 1999; 229:97–105PubMedCrossRef
27.
Zurück zum Zitat Charlson ME, Sax FL, MacKenzie CR, et al. Assessing illness severity: does clinical judgment work? J Chronic Dis 1986; 39:439–52PubMedCrossRef Charlson ME, Sax FL, MacKenzie CR, et al. Assessing illness severity: does clinical judgment work? J Chronic Dis 1986; 39:439–52PubMedCrossRef
28.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373–83PubMedCrossRef Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373–83PubMedCrossRef
29.
Zurück zum Zitat Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47:1245–51PubMedCrossRef Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47:1245–51PubMedCrossRef
30.
Zurück zum Zitat Uren RF, Howman-Giles R, Thompson JF, et al. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003; 44:570–82PubMed Uren RF, Howman-Giles R, Thompson JF, et al. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003; 44:570–82PubMed
31.
Zurück zum Zitat De Wilt JH, Thompson JF, Uren RF, et al. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg 2004; 239:544–52PubMedCrossRef De Wilt JH, Thompson JF, Uren RF, et al. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg 2004; 239:544–52PubMedCrossRef
32.
Zurück zum Zitat Poulsen M, Rischin D, Walpole E, et al. Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study. Int J Radiat Oncol Biol Phys 2001; 51:153–63CrossRef Poulsen M, Rischin D, Walpole E, et al. Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study. Int J Radiat Oncol Biol Phys 2001; 51:153–63CrossRef
33.
Zurück zum Zitat Poulsen M, Rischin D, Walpole E, et al. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study—TROG 96:07. J Clin Oncol 2003; 21:4371–6PubMedCrossRef Poulsen M, Rischin D, Walpole E, et al. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study—TROG 96:07. J Clin Oncol 2003; 21:4371–6PubMedCrossRef
34.
Zurück zum Zitat Venness MJ, Perera L, McCourt J, et al. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. Aust N Z J Surg 2005; 75:275–81CrossRef Venness MJ, Perera L, McCourt J, et al. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. Aust N Z J Surg 2005; 75:275–81CrossRef
35.
Zurück zum Zitat Ott MJ, Tanabe KK, Gadd MA, et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999; 134:388–93PubMedCrossRef Ott MJ, Tanabe KK, Gadd MA, et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999; 134:388–93PubMedCrossRef
36.
Zurück zum Zitat Wilder RB, Harari PM, Graham AR, et al. Improved locoregional control with postoperative radiation therapy. Cancer 1991; 68:1004–8PubMedCrossRef Wilder RB, Harari PM, Graham AR, et al. Improved locoregional control with postoperative radiation therapy. Cancer 1991; 68:1004–8PubMedCrossRef
37.
Zurück zum Zitat Marks ME, Kim RY, Salter MM. Radiotherapy as an adjunct in the management of Merkel cell carcinoma. Cancer 1990; 5:60–4CrossRef Marks ME, Kim RY, Salter MM. Radiotherapy as an adjunct in the management of Merkel cell carcinoma. Cancer 1990; 5:60–4CrossRef
38.
Zurück zum Zitat Tennvall J, Biorklund A, Johansson L, et al. Merkel cell carcinoma: management of primary, recurrent and metastatic disease. A clinicopathologic study of 17 patients. Eur J Surg Oncol 1989; 15:1–9PubMed Tennvall J, Biorklund A, Johansson L, et al. Merkel cell carcinoma: management of primary, recurrent and metastatic disease. A clinicopathologic study of 17 patients. Eur J Surg Oncol 1989; 15:1–9PubMed
39.
Zurück zum Zitat Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001; 127:149–54PubMed Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001; 127:149–54PubMed
40.
Zurück zum Zitat Morrison WH, Peters LJ, Silva EG, et al. The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1990; 19:583–91PubMed Morrison WH, Peters LJ, Silva EG, et al. The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1990; 19:583–91PubMed
41.
Zurück zum Zitat Bielamowicz S, Smith D, Abemayor E. Merkel cell carcinoma: an aggressive skin neoplasm. Laryngoscope 1990; 104:528–32CrossRef Bielamowicz S, Smith D, Abemayor E. Merkel cell carcinoma: an aggressive skin neoplasm. Laryngoscope 1990; 104:528–32CrossRef
42.
Zurück zum Zitat Wong KC, Zuletta F, Clarke J, et al. Clinical management and treatment outcomes of Merkel cell carcinoma. Aust N Z J Surg 1998; 68:354–8PubMed Wong KC, Zuletta F, Clarke J, et al. Clinical management and treatment outcomes of Merkel cell carcinoma. Aust N Z J Surg 1998; 68:354–8PubMed
43.
44.
Zurück zum Zitat Perez JA, Poblete MT, Castillo P, et al. Merkel cell carcinoma. Report of 4 cases (in Spanish). Rev Med Chil 1998;126:553–8PubMed Perez JA, Poblete MT, Castillo P, et al. Merkel cell carcinoma. Report of 4 cases (in Spanish). Rev Med Chil 1998;126:553–8PubMed
45.
Zurück zum Zitat Pergolizzi J, Pelczar M, Conaway GL. Merkel cell carcinoma: an aggressive malignancy. Am Surg 1997; 63:450–4PubMed Pergolizzi J, Pelczar M, Conaway GL. Merkel cell carcinoma: an aggressive malignancy. Am Surg 1997; 63:450–4PubMed
46.
Zurück zum Zitat Boyer JD, Zitelli JA, Brodland DG, et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. Dermatol Surg 2002; 47:885–92 Boyer JD, Zitelli JA, Brodland DG, et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. Dermatol Surg 2002; 47:885–92
47.
Zurück zum Zitat Veness MJ. Merkel cell carcinoma: improved outcome with the addition of adjuvant therapy. J Clin Oncol 2005; 23:7235–6PubMedCrossRef Veness MJ. Merkel cell carcinoma: improved outcome with the addition of adjuvant therapy. J Clin Oncol 2005; 23:7235–6PubMedCrossRef
48.
Zurück zum Zitat Bourne RG, O’Rourke MG. Management of Merkel cell tumour. Aust N Z J Surg 1988; 58:971–4PubMed Bourne RG, O’Rourke MG. Management of Merkel cell tumour. Aust N Z J Surg 1988; 58:971–4PubMed
49.
Zurück zum Zitat Smith DE, Bielamowicz S, Kagan AR, et al. Cutaneous neuroendocrine (Merkel cell) carcinoma. Am J Clin Oncol 1995; 18:199–204PubMedCrossRef Smith DE, Bielamowicz S, Kagan AR, et al. Cutaneous neuroendocrine (Merkel cell) carcinoma. Am J Clin Oncol 1995; 18:199–204PubMedCrossRef
50.
Zurück zum Zitat Mehrany K, Otley CC, Weenig RH, et al. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002; 28:113–7PubMedCrossRef Mehrany K, Otley CC, Weenig RH, et al. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002; 28:113–7PubMedCrossRef
51.
Zurück zum Zitat Victor NS, Morton B, Smith JW. Merkel cell cancer: is prophylactic lymph node dissection indicated? Am Surg 1996; 62:879–82PubMed Victor NS, Morton B, Smith JW. Merkel cell cancer: is prophylactic lymph node dissection indicated? Am Surg 1996; 62:879–82PubMed
52.
Zurück zum Zitat Gollard R, Weber R, Kosty MP, et al. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer 2000; 88:1842–51PubMedCrossRef Gollard R, Weber R, Kosty MP, et al. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer 2000; 88:1842–51PubMedCrossRef
53.
Zurück zum Zitat Eich HT, Eich D, Staar S, et al. Role of post-operative radiotherapy in the management of Merkel cell carcinoma. Am J Clin Oncol 2002; 25:50–6PubMedCrossRef Eich HT, Eich D, Staar S, et al. Role of post-operative radiotherapy in the management of Merkel cell carcinoma. Am J Clin Oncol 2002; 25:50–6PubMedCrossRef
54.
Zurück zum Zitat Voog E, Biron P, Martin JP, et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999;15:2589–95CrossRef Voog E, Biron P, Martin JP, et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999;15:2589–95CrossRef
55.
Zurück zum Zitat Haag M, Glass LF, Fenske NA. Merkel cell carcinoma: diagnosis and treatment. Dermatol Surg 1995; 21:669–83PubMedCrossRef Haag M, Glass LF, Fenske NA. Merkel cell carcinoma: diagnosis and treatment. Dermatol Surg 1995; 21:669–83PubMedCrossRef
56.
Zurück zum Zitat Suntharalingam M, Rudoltz M, Mendenhall W, et al. Radiotherapy for Merkel cell carcinoma of the skin of the head and neck. Head Neck 1995; 17:96–101PubMedCrossRef Suntharalingam M, Rudoltz M, Mendenhall W, et al. Radiotherapy for Merkel cell carcinoma of the skin of the head and neck. Head Neck 1995; 17:96–101PubMedCrossRef
57.
Zurück zum Zitat Raaf JH, Urmacher C, Knapper WK, et al. Trabecular (Merkel cell) carcinoma of the skin: treatment of primary, recurrent, and metastatic disease. Cancer 1986; 57:178–82PubMedCrossRef Raaf JH, Urmacher C, Knapper WK, et al. Trabecular (Merkel cell) carcinoma of the skin: treatment of primary, recurrent, and metastatic disease. Cancer 1986; 57:178–82PubMedCrossRef
58.
Zurück zum Zitat Pilotti S, Rilke F, Bartoli C, et al. Clinicopathologic correlations of cutaneous neuroendocrine Merkel cell carcinoma. J Clin Oncol 1988; 6:1863–73PubMed Pilotti S, Rilke F, Bartoli C, et al. Clinicopathologic correlations of cutaneous neuroendocrine Merkel cell carcinoma. J Clin Oncol 1988; 6:1863–73PubMed
59.
Zurück zum Zitat Silva EG, Mackay B, Goepfert H, et al. Endocrine carcinoma of the skin (Merkel cell carcinoma). Pathol Ann 1984; 19:1–30 Silva EG, Mackay B, Goepfert H, et al. Endocrine carcinoma of the skin (Merkel cell carcinoma). Pathol Ann 1984; 19:1–30
60.
Zurück zum Zitat Pitale M, Sessions RB, Husain S. An analysis of prognostic factors in cutaneous neuroendocrine carcinoma. Laryngoscope 1992; 102:244–9PubMedCrossRef Pitale M, Sessions RB, Husain S. An analysis of prognostic factors in cutaneous neuroendocrine carcinoma. Laryngoscope 1992; 102:244–9PubMedCrossRef
61.
Zurück zum Zitat Cotlar AM, Gates JO, Gibbs FA. Merkel cell carcinoma: combined surgery and radiation therapy. Am Surg 1986; 52:159–64PubMed Cotlar AM, Gates JO, Gibbs FA. Merkel cell carcinoma: combined surgery and radiation therapy. Am Surg 1986; 52:159–64PubMed
62.
Zurück zum Zitat Tsang G, O’Brien P, Robertson R, et al. All delays before radiotherapy risk progression of Merkel cell carcinoma. Australas Radiol 2004; 48:371–5PubMedCrossRef Tsang G, O’Brien P, Robertson R, et al. All delays before radiotherapy risk progression of Merkel cell carcinoma. Australas Radiol 2004; 48:371–5PubMedCrossRef
63.
Zurück zum Zitat Bischof M, Van Kampen M, Huber P, et al. Merkel cell carcinoma: the role of radiation therapy in general management. Strahlenther Onkol 1999; 175:611–5PubMedCrossRef Bischof M, Van Kampen M, Huber P, et al. Merkel cell carcinoma: the role of radiation therapy in general management. Strahlenther Onkol 1999; 175:611–5PubMedCrossRef
64.
Zurück zum Zitat Gould EV, Moll R, Moll I, et al. Biology of disease: neuroendocrine (Merkel) cells of the skin—hyperplasias, dysplasias, and neoplasms. Lab Invest 1985; 52:334–53PubMed Gould EV, Moll R, Moll I, et al. Biology of disease: neuroendocrine (Merkel) cells of the skin—hyperplasias, dysplasias, and neoplasms. Lab Invest 1985; 52:334–53PubMed
65.
Zurück zum Zitat Ratner D, Nelson BR, Brown MD, et al. Merkel cell carcinoma. J Am Acad Dermatol 1999; 29:143–56CrossRef Ratner D, Nelson BR, Brown MD, et al. Merkel cell carcinoma. J Am Acad Dermatol 1999; 29:143–56CrossRef
66.
Zurück zum Zitat Al-Ghazal SK, Arora DS, Simpson RH, et al. Merkel cell carcinoma of the skin. Br J Plast Surg 1996; 49:491–6PubMedCrossRef Al-Ghazal SK, Arora DS, Simpson RH, et al. Merkel cell carcinoma of the skin. Br J Plast Surg 1996; 49:491–6PubMedCrossRef
67.
Zurück zum Zitat Buell JF, Trofe J, Hanaway MJ, et al. Immunosuppression and Merkel cell cancer. Transplant Proc 2002; 34:1780–1PubMedCrossRef Buell JF, Trofe J, Hanaway MJ, et al. Immunosuppression and Merkel cell cancer. Transplant Proc 2002; 34:1780–1PubMedCrossRef
68.
Zurück zum Zitat Bordea C, Wonjnarowska F, Millard PR, et al. Skin cancers in renal-transplant recipients occur more commonly than previously recognized in a temperate climate. Transplantation 2004; 77:574–9PubMedCrossRef Bordea C, Wonjnarowska F, Millard PR, et al. Skin cancers in renal-transplant recipients occur more commonly than previously recognized in a temperate climate. Transplantation 2004; 77:574–9PubMedCrossRef
69.
Zurück zum Zitat Engels E, Frisch M, Goedart J, et al. Merkel cell carcinoma and HIV infection. Lancet 2002; 359:497–8PubMedCrossRef Engels E, Frisch M, Goedart J, et al. Merkel cell carcinoma and HIV infection. Lancet 2002; 359:497–8PubMedCrossRef
70.
Zurück zum Zitat Scott MP, Helm KF. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Am J Dermatopathol 1999; 21:16–20PubMedCrossRef Scott MP, Helm KF. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Am J Dermatopathol 1999; 21:16–20PubMedCrossRef
71.
Zurück zum Zitat Hanly AJ, Elgart GW, Jorda M, et al. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates Merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol 2000; 27:118–20PubMedCrossRef Hanly AJ, Elgart GW, Jorda M, et al. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates Merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol 2000; 27:118–20PubMedCrossRef
72.
Zurück zum Zitat Haneke E, Schulze HJ, Mahrle G, et al. Immunohistochemical and immunoelectron microscopic demonstration of chromogranin A in formalin-fixed tissue of Merkel cell carcinoma. J Am Acad Dermatol 1993; 28:222–6PubMed Haneke E, Schulze HJ, Mahrle G, et al. Immunohistochemical and immunoelectron microscopic demonstration of chromogranin A in formalin-fixed tissue of Merkel cell carcinoma. J Am Acad Dermatol 1993; 28:222–6PubMed
Metadaten
Titel
Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease—Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004
verfasst von
James Jabbour, BSc(Med), MBBS, MPH
Robert Cumming, MBBS, MPH, PhD
Richard A. Scolyer, MD, FRCPA
George Hruby, MBBS, FRANZCR
John F. Thompson, MD, FRACS
Stephen Lee, MBBS, FACD
Publikationsdatum
01.06.2007
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2007
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9327-y

Weitere Artikel der Ausgabe 6/2007

Annals of Surgical Oncology 6/2007 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.